It has been observed that the RANKL/osteoprotegerin ratio increases in patients with periodontitis compared to healthy subjects, indicating that the RANKL/osteoprotegerin interaction may be critical in modulating alveolar bone loss during periodontitis [24,105]. Here, TNFRSF11B is linked to periodontitis.